期刊
BIOORGANIC & MEDICINAL CHEMISTRY
卷 22, 期 22, 页码 6459-6470出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2014.09.036
关键词
8-Amino imidazo[1,2-a]pyrazine; Bacterial type IV secretion system; HP0525; ATPase inhibitor
资金
- BBSRC [BBS/SE/2006/1326/9, BBS/K/2005/12145, BB/D005469/1]
- Wellcome Trust [082227, 096617/Z/11/Z]
- UCLB
- BBSRC [BB/D005469/1] Funding Source: UKRI
- Wellcome Trust [096617/Z/11/Z] Funding Source: Wellcome Trust
- Biotechnology and Biological Sciences Research Council [BB/D005469/1] Funding Source: researchfish
A novel series of 8-amino imidazo[1,2-a] pyrazine derivatives has been developed as inhibitors of the VirB11 ATPase HP0525, a key component of the bacterial type IV secretion system. A flexible synthetic route to both 2- and 3-aryl substituted regioisomers has been developed. The resulting series of imidazo[1,2-a] pyrazines has been used to probe the structure-activity relationships of these inhibitors, which show potential as antibacterial agents. (C) 2014 The Authors. Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据